301331 logo

Enwei Pharmaceutical Co., Ltd. Stock Price

SZSE:301331 Community·CN¥2.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

301331 Share Price Performance

CN¥0
-24.36 (-100.00%)
CN¥0
-24.36 (-100.00%)
Price CN¥0

301331 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with proven track record.

2 Risks
1 Reward

Enwei Pharmaceutical Co., Ltd. Key Details

CN¥888.6m

Revenue

CN¥459.1m

Cost of Revenue

CN¥429.6m

Gross Profit

CN¥377.5m

Other Expenses

CN¥52.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 27, 2026
0.52
48.34%
5.86%
17.7%
View Full Analysis

About 301331

Founded
2005
Employees
1548
CEO
Yongjiang Xue
WebsiteView website
www.enwei.com.cn

Enwei Pharmaceutical Co., Ltd. engages in the development and sale of Chinese medicines in China. The company offers drugs in the areas of gynecology, pediatrics, and respiratory system fields. The company was founded in 2005 and is based in Chengdu, China.

Recent 301331 News & Updates

Recent updates

No updates